These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 18981653)

  • 1. A case of obstructive jaundice with severe hypercholesterolemia probably due to lipoprotein-Y.
    Murano T; Oyama T; Miyashita Y; Shirai K
    J Atheroscler Thromb; 2008 Oct; 15(5):276-80. PubMed ID: 18981653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B-100 deficiency. Intestinal steatosis despite apolipoprotein B-48 synthesis.
    Herbert PN; Hyams JS; Bernier DN; Berman MM; Saritelli AL; Lynch KM; Nichols AV; Forte TM
    J Clin Invest; 1985 Aug; 76(2):403-12. PubMed ID: 4031057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of cholesterol-rich lipoproteins by perfused livers of hypercholesterolemic rats.
    Noel SP; Wong L; Dolphin PJ; Dory L; Rubenstein D
    J Clin Invest; 1979 Aug; 64(2):674-83. PubMed ID: 222814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
    Ballantyne CM; Pitt B; Loscalzo J; Cain VA; Raichlen JS
    Am J Cardiol; 2013 Feb; 111(4):506-9. PubMed ID: 23237107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: effects of incubation with lecithin: cholesterol acyltransferase in vitro.
    Norum KR; Glomset JA; Nichols AV; Forte T; Albers JJ; King WC; Mitchell CD; Applegate KR; Gong EL; Cabana V
    Scand J Clin Lab Invest Suppl; 1975; 142():31-55. PubMed ID: 169567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between charge-based apolipoprotein B-containing lipoprotein subfractions and remnant-like particle cholesterol levels.
    Zhang B; Böttcher A; Imaizumi S; Noda K; Schmitz G; Saku K
    Atherosclerosis; 2007 Mar; 191(1):153-61. PubMed ID: 16620837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lipoprotein fraction between VLDL and LDL detected by biphasic agarose gel electrophoresis reflects serum remnant lipoprotein and Lp(a) concentrations.
    Sato I; Taniguchi T; Ishikawa Y; Kusuki M; Hayashi F; Mukai M; Kawano S; Kondo S; Yamashita S; Kumagai S
    J Atheroscler Thromb; 2006 Feb; 13(1):55-61. PubMed ID: 16505592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of hyper-HDL-cholesterolemia presenting peculiar lipoprotein patterns in agarose gel electrophoresis].
    Hoshino T; Yamashita S; Sakai N; Matsuzawa Y; Tarui S; Kumasaka K
    Rinsho Byori; 1989 Jul; 37(7):835-9. PubMed ID: 2607652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis.
    Forte TM; Nichols AV; Krauss RM; Norum RA
    J Clin Invest; 1984 Nov; 74(5):1601-13. PubMed ID: 6501564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S; Matsumoto M; Nagao K; Hirayama A
    J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study.
    Tani S; Takahashi A; Nagao K; Hirayama A
    Heart Vessels; 2016 Jun; 31(6):831-40. PubMed ID: 25894629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
    Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
    J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.